Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schjøtt J[au]:

Ciprofloxacin and acute aortic valve damage. Schjøtt J et al. Med Hypotheses. (2018)

[Drug use in blood donors]. Berg JA et al. Tidsskr Nor Laegeforen. (2016)

Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective. Pettersen TR et al. Int J Nurs Stud. (2018)

Search results

Items: 1 to 50 of 91

1.

Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI).

Norekvål TM, Allore HG, Bendz B, Bjorvatn C, Borregaard B, Brørs G, Deaton C, Fålun N, Hadjistavropoulos H, Hansen TB, Igland S, Larsen AI, Palm P, Pettersen TR, Rasmussen TB, Schjøtt J, Søgaard R, Valaker I, Zwisler AD, Rotevatn S; CONCARD Investigators.

BMJ Open. 2020 Feb 12;10(2):e031995. doi: 10.1136/bmjopen-2019-031995.

2.

Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells.

Bjånes T, Kotopoulis S, Murvold ET, Kamčeva T, Gjertsen BT, Gilja OH, Schjøtt J, Riedel B, McCormack E.

Pharmaceutics. 2020 Feb 7;12(2). pii: E141. doi: 10.3390/pharmaceutics12020141.

3.

Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.

Bjånes TK, Jordheim LP, Schjøtt J, Kamceva T, Cros-Perrial E, Langer A, Ruiz de Garibay G, Kotopoulis S, McCormack E, Riedel B.

Drug Metab Dispos. 2020 Mar;48(3):153-158. doi: 10.1124/dmd.119.089334. Epub 2019 Dec 23.

PMID:
31871136
4.

Distribution of Psychotropic Drugs Into Lipoproteins.

Serkland TT, Schjøtt J, Berg JA, Herfindal L, Riedel B, Skrede S.

Ther Drug Monit. 2019 Dec;41(6):766-771. doi: 10.1097/FTD.0000000000000660.

PMID:
31725695
5.

Analysis of consensus among drug interaction databases with regard to combinations of psychotropics.

Schjøtt J, Schjøtt P, Assmus J.

Basic Clin Pharmacol Toxicol. 2020 Feb;126(2):126-132. doi: 10.1111/bcpt.13312. Epub 2019 Sep 12.

PMID:
31468698
6.

Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).

Stokes CL, Schjøtt J.

Eur J Clin Pharmacol. 2019 Oct;75(10):1469-1470. doi: 10.1007/s00228-019-02717-x. Epub 2019 Jul 12. No abstract available.

PMID:
31300837
7.

Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Schjøtt J.

EPMA J. 2019 Apr 30;10(2):109-114. doi: 10.1007/s13167-019-00167-0. eCollection 2019 Jun. Review.

PMID:
31258816
8.
9.

Short communication: Distribution of psychotropic drugs into lipoproteins.

Serkland TT, Schjøtt J, Berg JA, Herfindal L, Riedel B, Skrede S.

Ther Drug Monit. 2019 May 23. doi: 10.1097/FTD.0000000000000660. [Epub ahead of print]

PMID:
31136418
10.

Stability of Antidepressants and Antipsychotics in Gel Separator Tubes.

Berg JA, Schjøtt J, Carstensen K, Fossan KO, Skrede S, Bjånes TK, Serkland TT, Riedel B.

Ther Drug Monit. 2019 Apr;41(2):249-250. doi: 10.1097/FTD.0000000000000603. No abstract available.

PMID:
30883518
11.

Drug information centres and their provision of decision support: The Scandinavian experience.

Schjøtt J, Spigset O.

J Clin Pharm Ther. 2019 Jun;44(3):489-492. doi: 10.1111/jcpt.12804. Epub 2019 Feb 1.

PMID:
30710370
12.

The Possibility of Therapeutic Drug Monitoring of the Most Important Interactions in Nursing Homes.

Schjøtt P, Šutovská M, Schjøtt J.

Curr Clin Pharmacol. 2019;14(2):152-156. doi: 10.2174/1574884714666181224144722.

PMID:
30585548
13.

Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Rekeland IG, Fluge Ø, Alme K, Risa K, Sørland K, Mella O, de Vries A, Schjøtt J.

Clin Ther. 2019 May;41(5):806-814. doi: 10.1016/j.clinthera.2018.10.019. Epub 2018 Nov 28.

PMID:
30502905
14.

Ciprofloxacin and acute aortic valve damage.

Schjøtt J, Messner T.

Med Hypotheses. 2018 Dec;121:35. doi: 10.1016/j.mehy.2018.09.013. Epub 2018 Sep 8. No abstract available.

PMID:
30396483
15.

Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.

Pettersen TR, Fridlund B, Bendz B, Nordrehaug JE, Rotevatn S, Schjøtt J, Norekvål TM; CONCARD Investigators.

Int J Nurs Stud. 2018 Dec;88:16-24. doi: 10.1016/j.ijnurstu.2018.07.013. Epub 2018 Jul 26.

PMID:
30165236
16.

Use of References in Responses from Scandinavian Drug Information Centres.

Schjøtt J, Böttiger Y, Damkier P, Reppe LA, Kampmann JP, Christensen HR, Spigset O.

Medicines (Basel). 2018 Jul 1;5(3). pii: E66. doi: 10.3390/medicines5030066.

17.

Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.

Jahnsen JA, Widnes SF, Schjøtt J.

Int Breastfeed J. 2018 Jan 9;13:1. doi: 10.1186/s13006-017-0143-8. eCollection 2018.

18.

Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015.

Schjøtt J.

Aging Clin Exp Res. 2018 Jul;30(7):867-870. doi: 10.1007/s40520-017-0832-6. Epub 2017 Sep 19.

PMID:
28929445
19.

Shortage of Digitoxin and Switching to Digoxin in Norway: A Retrospective Study of Blood Samples Submitted to a Clinical Pharmacology Laboratory.

Schjøtt J, Torgauten HM, Bjånes TK.

Basic Clin Pharmacol Toxicol. 2017 Jul;121(1):74-77. doi: 10.1111/bcpt.12770. Epub 2017 Mar 15. No abstract available.

20.

Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.

Reppe LA, Spigset O, Kampmann JP, Damkier P, Christensen HR, Böttiger Y, Schjøtt J.

Eur J Clin Pharmacol. 2017 May;73(5):623-631. doi: 10.1007/s00228-017-2209-3. Epub 2017 Feb 5.

21.

Risk perception regarding drug use in pregnancy.

Widnes SF, Schjøtt J.

Am J Obstet Gynecol. 2017 Apr;216(4):375-378. doi: 10.1016/j.ajog.2016.12.007. Epub 2016 Dec 14.

22.

A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer.

Dimcevski G, Kotopoulis S, Bjånes T, Hoem D, Schjøtt J, Gjertsen BT, Biermann M, Molven A, Sorbye H, McCormack E, Postema M, Gilja OH.

J Control Release. 2016 Dec 10;243:172-181. doi: 10.1016/j.jconrel.2016.10.007. Epub 2016 Oct 12.

23.

Benefits of a national network of drug information centres: RELIS.

Schjøtt J.

Eur J Clin Pharmacol. 2017 Jan;73(1):125-126. doi: 10.1007/s00228-016-2129-7. Epub 2016 Sep 15. No abstract available.

24.

Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in Scandinavia.

Amundstuen Reppe L, Lydersen S, Schjøtt J, Damkier P, Rolighed Christensen H, Peter Kampmann J, Böttiger Y, Spigset O.

Clin Ther. 2016 Jul;38(7):1738-49. doi: 10.1016/j.clinthera.2016.05.010. Epub 2016 Jun 29.

25.

Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway.

Bakken MS, Schjøtt J, Engeland A, Engesaeter LB, Ruths S.

J Am Geriatr Soc. 2016 Jun;64(6):1203-9. doi: 10.1111/jgs.14162.

PMID:
27321599
26.

[Drug use in blood donors].

Berg JA, Schjøtt J.

Tidsskr Nor Laegeforen. 2016 May 3;136(8):718-20. doi: 10.4045/tidsskr.15.0650. eCollection 2016 May. Review. Norwegian. No abstract available.

27.

Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.

Bakkebø T, Widnes SF, Aamlid SS, Schjøtt J.

Clin Ther. 2016 May;38(5):1102-8. doi: 10.1016/j.clinthera.2016.02.018. Epub 2016 Mar 10.

PMID:
26973297
28.

Drug Information Services Today: Current Role and Future Perspectives in Rational Drug Therapy.

Amundstuen Reppe L, Spigset O, Schjøtt J.

Clin Ther. 2016 Feb;38(2):414-21. doi: 10.1016/j.clinthera.2015.12.019. Epub 2016 Jan 29.

PMID:
26831829
29.

Challenges in psychopharmacology: a drug information centre perspective.

Schjøtt J.

J Clin Pharm Ther. 2016 Feb;41(1):4-6. doi: 10.1111/jcpt.12354. Epub 2016 Jan 18.

PMID:
26775691
30.

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.

Berg JA, Schjøtt J, Fossan KO, Riedel B.

Subst Abuse Rehabil. 2015 Oct 28;6:131-9. doi: 10.2147/SAR.S88935. eCollection 2015.

31.

Preanalytical Stability of Gemcitabine and its Metabolite 2', 2'-Difluoro-2'-Deoxyuridine in Whole Blood-Assessed by Liquid Chromatography Tandem Mass Spectrometry.

Bjånes T, Kamčeva T, Eide T, Riedel B, Schjøtt J, Svardal A.

J Pharm Sci. 2015 Dec;104(12):4427-4432. doi: 10.1002/jps.24638. Epub 2015 Sep 15.

PMID:
26372902
32.

Liquid chromatography/tandem mass spectrometry method for simultaneous quantification of eight endogenous nucleotides and the intracellular gemcitabine metabolite dFdCTP in human peripheral blood mononuclear cells.

Kamčeva T, Bjånes T, Svardal A, Riedel B, Schjøtt J, Eide T.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:212-20. doi: 10.1016/j.jchromb.2015.07.041. Epub 2015 Aug 3.

PMID:
26281773
33.

[Re: Don't forget the Marevan!].

Langaas HC, Schjøtt J.

Tidsskr Nor Laegeforen. 2014 Nov 25;134(22):2125. doi: 10.4045/tidsskr.14.1356. eCollection 2014 Nov. Norwegian. No abstract available.

34.

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.

Reppe LA, Spigset O, Böttiger Y, Christensen HR, Kampmann JP, Damkier P, Lydersen S, Schjøtt J.

Eur J Clin Pharmacol. 2014 Nov;70(11):1395-401. doi: 10.1007/s00228-014-1749-z. Epub 2014 Sep 12.

35.

Myocardial injury in a 41-year-old male treated with methylphenidate: a case report.

Hole LD, Schjøtt J.

BMC Res Notes. 2014 Jul 29;7:480. doi: 10.1186/1756-0500-7-480.

36.

Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.

Schjøtt J, Bergman J.

Drug Healthc Patient Saf. 2014 Jul 1;6:89-92. doi: 10.2147/DHPS.S63680. eCollection 2014.

37.

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat.

Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J.

BMC Pharmacol Toxicol. 2014 May 27;15:28. doi: 10.1186/2050-6511-15-28.

38.

Morphine enhances doxorubicin-induced cardiotoxicity in the rat.

Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J.

Cardiovasc Toxicol. 2014 Sep;14(3):251-9. doi: 10.1007/s12012-014-9249-z.

39.
40.

A man in his seventies with a long-term infection and severe acid-base imbalance.

Holmaas G, Lærum JH, Schjøtt J, Leiva RA.

Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):315-9. doi: 10.4045/tidsskr.13.0430. English, Norwegian. No abstract available.

41.

[Medical treatment of neuropathic pain].

Slapø GD, Schjøtt J.

Tidsskr Nor Laegeforen. 2013 May 7;133(9):971-3. doi: 10.4045/tidsskr.12.0197. Norwegian.

42.

Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.

Widnes SF, Schjøtt J, Eide GE, Granas AG.

Drug Saf. 2013 Jun;36(6):481-9. doi: 10.1007/s40264-013-0035-9.

PMID:
23539202
43.

A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat.

Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J.

Toxicol Mech Methods. 2013 Jul;23(6):412-8. doi: 10.3109/15376516.2013.773391. Epub 2013 Apr 24.

PMID:
23379389
44.

A Blended Learning Course Design in Clinical Pharmacology for Post-graduate Dental Students.

Rosenbaum PE, Mikalsen O, Lygre H, Solheim E, Schjøtt J.

Open Dent J. 2012;6:182-7. doi: 10.2174/1874210601206010182. Epub 2012 Nov 30.

45.

Risk perception and medicines information needs in pregnant women with epilepsy--a qualitative study.

Widnes SF, Schjøtt J, Granas AG.

Seizure. 2012 Oct;21(8):597-602. doi: 10.1016/j.seizure.2012.06.007. Epub 2012 Jul 3.

46.
47.

Prevention of urinary tract infections in nursing homes: lack of evidence-based prescription?

Bergman J, Schjøtt J, Blix HS.

BMC Geriatr. 2011 Nov 1;11:69. doi: 10.1186/1471-2318-11-69.

48.

Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study.

Chalabianloo F, Berstad A, Schjøtt J, Riedel B, Irgens A, Florvaag E.

Pharmacoepidemiol Drug Saf. 2011 May;20(5):506-13. doi: 10.1002/pds.2134.

PMID:
21523851
49.

Which factors predict the time spent answering queries to a drug information centre?

Reppe LA, Spigset O, Schjøtt J.

Pharm World Sci. 2010 Dec;32(6):799-804. doi: 10.1007/s11096-010-9440-7. Epub 2010 Oct 5.

50.

How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes.

Blix HS, Bergman J, Schjøtt J.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1025-30. doi: 10.1002/pds.1980.

PMID:
20712026

Supplemental Content

Loading ...
Support Center